Unfortunately, for some of us it seems like it would take a minor miracle just to afford it
A glucagon-like peptide-1 (GLP-1) receptor agonist, it mimics the body's natural GLP-1 hormone to help regulate blood sugar levels
To view this lecture and archived videos of previous lectures, visit
These medications are usually prescribed for people who are obese (BMI 30) or overweight (BMI 27) with related health conditions, or to manage a chronic condition like type 2 diabetes
Greater understanding of trial generalizability is needed. In the cross-sectional study, the researchers examined a cohort of 8,767 participants aged 20 years or older from the National Health and Nutrition Examination Survey to determine proportions of those who were met the FDAs label criteria for weight loss treatment and those who met trial exclusion criteria
In fact, studies show that up to 50% of people using GLP-1 injectables like Ozempic report some form of reaction, many of which are tied to avoidable preparation errors